Nurturing and investing in emerging life science and tech companies
The o2h Group has a track record of nurturing and investing in emerging life science and tech companies, covering biotech, small molecule, biologics, digital health, software and green innovation.
o2h Group operates from their Mill SciTech Park where they are developing a unique model for incubating small life science companies. o2h co-work labs operates the park in Hauxton,
a place for entrepreneurs, scientists, techies and dreamers. Supported by high specification labs to create a genuinely unique environment for creativity and innovation to thrive.
The o2h Ventures ‘Human Health’ SEIS and EIS funds make tax-efficient investments in Pre-Seed and Seed stage companies that address human disease: they fund the development of novel therapeutic treatments; help build new services and tools offerings throughout the biotech ecosystem, and spur the creation of software and artificial intelligence that will change healthcare.
The o2h team are leaders in the biotech community and have been actively involved as investors, holding various board/industry positions as well as being engaged in grassroots scientific activity for over 20 years.
Click here for more details.